Immunopolarization of CD4+ and CD8+ T cells to type-1-like is associated with melanocyte loss in human vitiligo

Laboratory Investigation

Volumn 83, Issue 5, 2003, Pages 683-695

  Wańkowicz Kalińska, Anna ^a,d   Van den Wijngaard, René M J G J ^a   Tigges, Bert J ^a   Westerhof, Wiete ^a,b   Ogg, Graham S ^c   Cerundolo, Vincenzo ^c   Storkus, Walter J ^d   Das, Pranab K ^a,e  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Dutch Institute for Pigmentary Disorders (SNIP)   (Netherlands)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MELAN A;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL CLONING; CELL INFILTRATION; CELL LOSS; CLINICAL ARTICLE; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DEPIGMENTATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE CLONE; MALE; MELANOCYTE; PATHOGENESIS; POLARIZATION; PRIORITY JOURNAL; T LYMPHOCYTE; VITILIGO;

EID: 0038814059     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000069521.42488.1B     Document Type: Article

References (28)

1. al Badri AM, Foulis AK, Todd PM, Gariouch JJ, Gudgeon JE, Stewart DG, Gracie JA, and Goudie RB (1993). Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo. J Pathol 169:203-206.
2. Bos JD, Zonneveld I, Das PK, Krieg SR, van der Loos CM, and Kapsenberg ML (1987). The skin immune system (SIS): Distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol 88:569-573.
3. Carroll JM, Crompton T, Seery JP, and Watt FM (1997). Transgenic mice expressing IFN gamma in the epidermis have eczema, hair hypopigmentation, and hair loss. J Invest Dermatol 108:412-422.
4. Carter LL, and Dutton RW (1996). Type 1 and type 2: A fundamental dichotomy for all T-cell subsets. Curr Opin Immunol 8:336-342.
5. Comabella M, Balashov K, Issazadeh S, Smith D, Weiner HL, and Khoury SJ (1998). Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. J Clin Invest 102:671-678.
6. Del Prete GF, Vercelli D, Tiri A, Maggi E, Mariotti S, Pinchera A, Ricci M, and Romagnani S (1986). In vivo activated cytotoxic T cells in the thyroid infiltrate of patients with Hashimoto's thyroiditis. Clin Exp Immunol 65:140-147.
7. Harning R, Cui J, and Bystryn JC (1991). Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol 97:1078-1080.
8. Itoh N, Hanafusa T, Miyazaki A, Miyagawa J, Yamagata K, Yamamoto K, Waguri M, Imagawa A, Tamura S, and Inada M (1993). Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 92:2313-2322.
9. Jurewicz A, Biddison WE, and Antel JP (1998). MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J Immunol 160:3056-3059.
10. Kagi D, Ho A, Odemmatt B, Zakarian A, Ohashi PS, and Mak TW (1999). TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes. J Immunol 162:4598-4605.
11. Kemp EH, Waterman EA, Hawes BE, O'Neill K, Gottumukkala RVSRK, Gawkrodger DJ, Weetman AP, and Watson PF (2002). The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo. J Clin Invest 109:923-930.
12. + T cell cytokine profile in experimental allergic encephalomyelitis. Eur J Immunol 27:2840-2847.
13. + T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/Mart1. J Invest Dermatol 116:891-897.
14. Lee KH, Wang E, Nielsen MB, Wunderlich J, Migueles S, Connors M, Steinberg SM, Rosenberg SA, and Marincola FM (1999). Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression. J Immunol 163:6292-6300.
15. Le Poole IC, Mutis T, van den Wijngaard RM, Westerhof W, Ottenhoff T, de Vries RR, and Das PK (1993a). A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders. J Immunol 151:7284-7292.
16. Le Poole IC, van den Wijngaard RM, Westerhof W, and Das PK (1996). Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 148:1219-1228.
17. Le Poole IC, van den Wijngaard RM, Westerhof W, Dutrieux RP, and Das PK (1993b). Presence or absence of melanocytes in vitiligo lesions: An immunohistochemical investigation. J Invest Dermatol 100:816-822.
18. + T cells in the pathogenesis of organ specific autoimmune diseases. Immunol Today 16:34-38.
19. Mosmann TR and Sad S (1996). The expanding universe of T cell subsets: Th1, Th2 and more. Immunol Today 17:138-146.
20. Ogg GS, Rod Dunbar P, Romero P, Chen JL, and Cerundolo V (1998). High frequency of skin-homing melanocytes-specific cytotoxic T lymphocytes in autoimmune vitiligo. J Exp Med 188:1203-1208.
21. Palermo B, Campanelli R, Garbelli S, Manovani S, Lantelme E, Brazzelli V, Ardigo M, Borroni G, Martinetti M, Badulli C, Necker A, and Giachino C (2001). Specific cytotoxic T lymphocyte responses against Melan-A/Mart1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: The role of cellular immunity in the etiopathogenesis of vitiligo. J Invest Dermatol 117:326-332.
22. Selmaj K and Raine CS (1988). Tumor necrosis factor mediates myelin damage in organotypic cultures of nervous tissue. Ann NY Acad Sci 540:568-570.
23. Shresta S, Smyth JR Jr, and Erf GF (1997). Profiles of pulp infiltrating lymphocytes at various times throughout feather regeneration in Smyth line chickens with vitiligo. Autoimmunity 25:193-201.
24. + T cell lines/clones derived from autoimmune thyroiditis lesions. They recognize self-thyroid antigens directly on TEC to exhibit T helper cell 1-type lymphokine production and cytotoxicity against TEC. J Immunol 155:1619-1628.
25. van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, Tigges B, Westerhof W, and Das PK (2000). Local immune response in skin of generalized vitiligo patients: Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest 80:1299-1309.
26. Verhagen CE, Wierenga EA, Buffing AA, Chand MA, Faber WR, and Das PK (1997). Reversal reaction in borderline leprosy is associated with a polarized shift to type 1-like mycobacterium leprae T cell reactivity in lesional skin: A follow-up study. J Immunol 159:4474-4483.
27. Wierenga EA, Snoek M, Jansen HM, Bos JD, van Lier RA, and Kapsenberg ML (1991). Human atopen-specific types 1 and 2 T helper cell clones. J Immunol 147:2942-2949.
28. Yee C, Thompson JA, Roche P, Byrd DR, Lee PP, Piepkorn M, Kenyon K, Davis MM, Riddel SR, and Greenberg PD (2000). Melanocyte destruction after antigen-spec(fic (immunotherapy of melanoma: direct evidence of T cell-mediated vitiligo. J Exp Med 192:1637-1643.